Lars Stegger

Albert Schweitzer Str. 33
Muenster, NW 48149, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Efficacy and outcomes of [177Lu]Lu-PSMA-617 in patients with mCRPC treated with or without concurrent ARPI: a real-world single-center analysis.

Efficacy and outcomes of [177Lu]Lu-PSMA-617 in patients with mCRPC treated with or without concurrent ARPI: a real-world single-center analysis.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 23, 2026

177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public.

177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public.

Journal: Nuklearmedizin. Nuclear medicine
Published: January 29, 2026

FAP-targeted [68Ga]BED003-PET in different solid malignancies.

FAP-targeted [68Ga]BED003-PET in different solid malignancies.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 12, 2025

Impact of pretreatment PET/MRI on radiooncologic target delineation in Hodgkin's lymphoma: a case series.

Impact of pretreatment PET/MRI on radiooncologic target delineation in Hodgkin's lymphoma: a case series.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: February 13, 2025

177 Lu-DOTATATE (Lutathera) Therapy in 68 Ga-DOTATATE PET/CT-Negative Liver Metastases of a Neuroendocrine Tumor.

177 Lu-DOTATATE (Lutathera) Therapy in 68 Ga-DOTATATE PET/CT-Negative Liver Metastases of a Neuroendocrine Tumor.

Journal: Clinical nuclear medicine
Published: October 26, 2023

PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL).

PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL).

Journal: European journal of nuclear medicine and molecular imaging
Published: June 28, 2023

Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer.

Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer.

Journal: Cardiovascular and interventional radiology
Published: June 26, 2023

Robustness of apparent diffusion coefficient-based lymph node classification for diagnosis of prostate cancer metastasis.

Robustness of apparent diffusion coefficient-based lymph node classification for diagnosis of prostate cancer metastasis.

Journal: European radiology
Published: June 01, 2023

First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study.

First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study.

Journal: EJNMMI research
Published: May 25, 2023

Discrepancy of PSMA PET imaging and bone scan showing limited value of bone scan and CT in evaluation of extent of bone involvement.

Discrepancy of PSMA PET imaging and bone scan showing limited value of bone scan and CT in evaluation of extent of bone involvement.

Journal: Nuklearmedizin. Nuclear medicine
Published: July 11, 2022

Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors.

Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 03, 2022

Radioembolization, Principles and indications.

Radioembolization, Principles and indications.

Journal: Nuklearmedizin. Nuclear medicine
Published: March 30, 2022
Showing 1-12 of 62

Last Updated: 09/26/2026